Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors.
J Clin Oncol
; 30(13): 1527-33, 2012 May 01.
Article
in En
| MEDLINE
| ID: mdl-22454420
Full text:
1
Database:
MEDLINE
Main subject:
Pyrimidines
/
Sulfonamides
/
Protein Kinase Inhibitors
/
Focal Adhesion Kinase 1
/
Focal Adhesion Kinase 2
/
Molecular Targeted Therapy
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged80
Country/Region as subject:
America do norte
/
Oceania
Language:
En
Journal:
J Clin Oncol
Year:
2012
Type:
Article
Affiliation country:
United States